| 2323 |
1852: Increased Ang II type 1 receptor (AT1R) |
1115: Increase, ROS |
Apr 10, 2021 |
Apr 10, 2021 |
2 AOPs
|
| 2066 |
1752: Increased AngII |
1743: Increase plasma Ang II |
Mar 17, 2020 |
Mar 17, 2020 |
None
|
| 2298 |
1752: Increased AngII |
1849: Impaired gustatory nerve |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2300 |
1752: Increased AngII |
1496: Increased proinflammatory mediators |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2317 |
1752: Increased AngII |
1856: Sodium inhibition, Sweet enhancement |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2327 |
1752: Increased AngII |
1852: Increased Ang II type 1 receptor (AT1R) |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2593 |
1752: Increased AngII |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R) |
Mar 3, 2022 |
Mar 3, 2022 |
1 AOP
|
| 1647 |
496: Decreased Leydig Cells |
413: Reduction, Testosterone synthesis in Leydig cells |
Aug 11, 2017 |
Aug 11, 2017 |
1 AOP
|
| 2030 |
1722: Increased blood CCK level |
1723: Increased acinar cell exocrine secretion |
Jan 8, 2020 |
Jan 8, 2020 |
1 AOP
|
| 1955 |
1663: brain Homocysteine level increases |
1664: Neuronal dysfunctions induction |
Jun 14, 2019 |
Jun 14, 2019 |
None
|
| 1579 |
1433: Increased CGRP |
1223: Increased Airway Hyper-responsiveness,Cough, Dyspnea |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1580 |
1433: Increased CGRP |
1343: Increase, hypertension |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1586 |
1433: Increased CGRP |
1225: Leukocyte infiltration |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1587 |
1433: Increased CGRP |
1226: Respiratory irritability |
Jun 27, 2017 |
Jun 27, 2017 |
1 AOP
|
| 51 |
39: Increased Cholinergic Signaling |
360: Decrease, Population growth rate |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 434 |
39: Increased Cholinergic Signaling |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 457 |
39: Increased Cholinergic Signaling |
445: Respiratory distress/arrest |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 2005 |
39: Increased Cholinergic Signaling |
1703: Cardiovascular dysregulation |
Nov 25, 2019 |
Dec 20, 2019 |
1 AOP
|
| 2011 |
39: Increased Cholinergic Signaling |
1705: Impaired coordination and movement |
Dec 20, 2019 |
Dec 20, 2019 |
1 AOP
|
| 2410 |
39: Increased Cholinergic Signaling |
386: Neuronal network function, Decreased |
Jun 24, 2021 |
Sep 1, 2021 |
1 AOP
|
| 2412 |
39: Increased Cholinergic Signaling |
402: Cognitive function, decreased |
Jun 24, 2021 |
Sep 1, 2021 |
1 AOP
|
| 3405 |
2280: Prolonged atrioventricular (AV) |
1106: Occurrence, cardiac arrhythmia |
Nov 20, 2024 |
Nov 20, 2024 |
2 AOPs
|
| 2031 |
1723: Increased acinar cell exocrine secretion |
1724: Acinar cell proliferation |
Jan 8, 2020 |
Jan 8, 2020 |
1 AOP
|
| 2876 |
2125: Increased fat mass |
1497: Recruitment of inflammatory cells |
Apr 5, 2023 |
Apr 5, 2023 |
1 AOP
|
| 2901 |
2125: Increased fat mass |
2132: Increased cytokine expression |
May 4, 2023 |
May 4, 2023 |
1 AOP
|